Castle Biosciences, Inc.CSTLNASDAQ
Loading
Operating Expenses Over TimeStrong
Percentile Rank100
3Y CAGR+16.2%
5Y CAGR+36.2%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+16.2%/yr
vs +69.9%/yr prior
5Y CAGR
+36.2%/yr
Recent deceleration
Acceleration
-53.7pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
4.7x
Strong expansion
Streak
8 yr
Consecutive growthStrong
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $279.16M | +6.1% |
| 2024 | $263.19M | +8.4% |
| 2023 | $242.78M | +36.5% |
| 2022 | $177.88M | +50.3% |
| 2021 | $118.34M | +98.9% |
| 2020 | $59.51M | +59.8% |
| 2019 | $37.23M | +74.6% |
| 2018 | $21.32M | +8.1% |
| 2017 | $19.73M | - |